Phase III trial indicates potential for melanoma vaccine.
D019496:Cancer Vaccines; D017326:Clinical Trials, Phase III as Topic; D003131:Combined Modality Therapy; D006801:Humans; D007167:Immunotherapy; D008545:Melanoma / Q000628:therapy*
D019496:Cancer Vaccines